EMA/HMA – First EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection held the 5 November 2025: publication of the Highlights and presentation materials
European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) were hosting the first EMA/HMA multi-stakeholder forum on EudraVigilance and signal Detection. The Forum’s main objectives were to inform stakeholders on ongoing and forthcoming developments...





